We are excited to welcome Novo Holdings as a new partner of the DQC.
Novo Holdings is the holding and investment company managing the assets and wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic foundations.
As part of the Novo Group, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S (formerly Novozymes A/S), and manages an investment portfolio with a long-term return perspective.
In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor investing in life science companies at all stages of development.
Commitment to build a quantum technology start-up ecosystem
In May 2024, Novo Holdings announced a commitment of €188 million to
build a quantum technology start-up ecosystem—marking the launch of a new quantum investments area. This initiative focuses on the transformative potential of quantum technologies across industries, especially within life science.
With the current momentum in Denmark, there is strong potential to
establish a global innovation hub for quantum technology. To achieve this, a
vibrant seed and venture capital investment ecosystem is essential—and that is exactly what Novo Holdings aims to accomplish.
As part of this strategy, Novo Holdings made its first direct quantum
investment in Sparrow Quantum in April 2024. The €21.5 million Series A round was co-led by PensionDanmark and EIFO, backed by 2xN, Liftt, and the European Innovation Council.
At DQC, we are excited to collaborate with Novo Holdings to further strengthen the Danish quantum ecosystem together.
To learn more about Novo Holdings, visit their website here.
